[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Life Sciences Market Research Reports & Industry Analysis

“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.

The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.

A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.

Publications found: 253,269
Sort by:

Post-Partum Depression Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major post-partum depression markets reached a value of US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 50.2 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 139 pages

Post-Traumatic Stress Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major post-traumatic stress disorder markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (...

May 2024 132 pages

Postmenopausal Vaginal Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major postmenopausal vaginal atrophy markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (...

May 2024 137 pages

Postoperative Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major postoperative pain markets reached a value of US$ 2,615.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,456.0 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 128 pages

Pouchitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pouchitis markets reached a value of US$ 51.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 117.6 Million by 2034, exhibiting a growth rate (CAGR) of 7.73% dur...

May 2024 137 pages

Prader-Willi Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Prader-Willi syndrome markets are expected to exhibit a CAGR of 3.65% during 2024-2034. The Prader-Willi syndrome market has been comprehensively analyzed in IMARC's new report titled 'Pra...

May 2024 133 pages

Precocious Puberty Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major precocious puberty markets are expected to exhibit a CAGR of 6.19% during 2024-2034. The precocious puberty market has been comprehensively analyzed in IMARC's new report titled 'Precociou...

May 2024 136 pages

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major prediabetes markets reached a value of US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 48.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.72% du...

May 2024 130 pages

Preeclampsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major preeclampsia markets reached a value of US$ 712.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 856.5 Million by 2034, exhibiting a growth rate (CAGR) of 1.69%...

May 2024 133 pages

Premature Ejaculation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major premature ejaculation markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 134 pages

Presbyopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major presbyopia markets are expected to exhibit a CAGR of 3.29% during 2024-2034. The presbyopia market has been comprehensively analyzed in IMARC's new report titled 'Presbyopia Market: Epidem...

May 2024 130 pages

Primary Biliary Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary biliary cholangitis markets reached a value of US$ 510 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,200 Million by 2034, exhibiting a growth rate (C...

May 2024 136 pages

Primary Gastric Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary gastric lymphoma markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.1 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Primary Immune Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary immune deficiency markets reached a value of US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.4 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 135 pages

Primary Myelofibrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary myelofibrosis markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The primary myelofibrosis market has been comprehensively analyzed in IMARC's new report titled 'Pri...

May 2024 140 pages

Primary Sclerosing Cholangitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major primary sclerosing cholangitis markets are expected to exhibit a CAGR of 5.84% during 2024-2034. The primary sclerosing cholangitis market has been comprehensively analyzed in IMARC's new...

May 2024 137 pages

Prinzmetal Angina Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Prinzmetal angina markets are expected to exhibit a CAGR of 3.8% during 2024-2034. The Prinzmetal angina market has been comprehensively analyzed in IMARC's new report titled 'Prinzmetal A...

May 2024 133 pages

Progressive Familial Intrahepatic Cholestasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major progressive familial intrahepatic cholestasis markets are expected to exhibit a CAGR of 4.68% during 2024-2034. The progressive familial intrahepatic cholestasis market has been comprehens...

May 2024 140 pages

Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The progressive pulmonary fibrosis (PPF) market has been comprehensively analyzed in IMARC's new report titled 'Progressive Pulmonary Fibrosis (PPF) Market: Epidemiology, Industry Trends, Share, Size,...

May 2024 134 pages

Proliferative Vitreoretinopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major proliferative vitreoretinopathy markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.1 Billion by 2034, exhibiting a growth rate...

May 2024 139 pages

Propionic Acidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major propionic acidemia markets are expected to exhibit a CAGR of 2.74% during 2024-2034. The propionic acidemia market has been comprehensively analyzed in IMARC's new report titled 'Propionic...

May 2024 137 pages

Proteinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major proteinuria markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.14% duri...

May 2024 129 pages

Proteus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The proteus syndrome market reached a value of US$ 1.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.8 Billion by 2034,...

May 2024 132 pages

Prurigo Nodularis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major prurigo nodularis markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The prurigo nodularis market has been comprehensively analyzed in IMARC's new report titled 'Prurigo Nod...

May 2024 140 pages

Pruritus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pruritus markets reached a value of US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.8 Billion by 2034, exhibiting a growth rate (CAGR) of 2.42% during...

May 2024 137 pages

Pseudoxanthoma Elasticum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pseudoxanthoma elasticum markets are expected to exhibit a CAGR of 1.21% during 2024-2034. The pseudoxanthoma elasticum market has been comprehensively analyzed in IMARC's new report title...

May 2024 135 pages

Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The psoriasis market reached a value of US$ 19.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 35.8 Billion by...

May 2024 133 pages

Psychomotor Agitation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major psychomotor agitation markets are expected to exhibit a CAGR of 1.92% during 2024-2034. The psychomotor agitation market has been comprehensively analyzed in IMARC's new report titled 'Psy...

May 2024 136 pages

Psychosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major psychosis markets reached a value of US$ 10.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.68% duri...

May 2024 138 pages

Ptosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ptosis markets reached a value of US$ 770.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,306.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.92% dur...

May 2024 136 pages

Pulmonary Embolism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary embolism markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 5.5...

May 2024 136 pages

Pulmonary Hypertension Associated with Interstitial Lung Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary hypertension associated with interstitial lung disease markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion b...

May 2024 134 pages

Pulmonary Sarcoidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pulmonary sarcoidosis markets reached a value of US$ 17.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 53.3 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 128 pages

Pyoderma Gangrenosum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pyoderma gangrenosum markets reached a value of US$ 126.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 185.1 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Pyruvate Kinase Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major pyruvate kinase deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The pyruvate kinase deficiency market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Raynaud's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Raynaud's disease markets are expected to exhibit a CAGR of 7.68% during 2024-2034. The Raynaud's disease market has been comprehensively analyzed in IMARC's new report titled 'Raynaud's D...

May 2024 131 pages

Recurrent Glioblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent glioblastoma markets are expected to exhibit a CAGR of 5.85% during 2024-2034. The recurrent glioblastoma market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Recurrent Head and Neck Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent head and neck squamous cell carcinoma markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.5 Billion by 2034, exhibitin...

May 2024 128 pages

Recurrent Malignant Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent malignant glioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 130 pages

Recurrent Pericarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major recurrent pericarditis markets are expected to exhibit a CAGR of 4.08% during 2024-2034. The recurrent pericarditis market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 134 pages

Relapsed Refractory Multiple Myeloma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major relapsed refractory multiple myeloma markets reached a value of US$ 21.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.4 Billion by 2034, exhibiting a growt...

May 2024 128 pages

Renal Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major renal cell carcinoma markets reached a value of US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 134 pages

Renal Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major renal insufficiency markets reached a value of US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.7 Billion by 2034, exhibiting a growth rate (CAGR) of 8...

May 2024 137 pages

Respiratory Distress Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major respiratory distress syndrome markets are expected to exhibit a CAGR of 4.56% during 2024-2034. The respiratory distress syndrome market has been comprehensively analyzed in IMARC's new re...

May 2024 133 pages

Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major respiratory syncytial virus markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Restless Legs Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major restless legs syndrome markets are expected to exhibit a CAGR of 2.49% during 2024-2034. The restless legs syndrome market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Retinal Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinal edema markets reached a value of US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.5 Billion by 2034, exhibiting a growth rate (CAGR) of 7.84% d...

May 2024 135 pages

Retinal Vein Occlusion Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinal vein occlusion markets reached a value of US$ 2,656.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,919.5 Million by 2034, exhibiting a growth rate (...

May 2024 132 pages

Retinitis Pigmentosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinitis pigmentosa markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 17.1 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Retinopathy of Prematurity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major retinopathy of prematurity markets are expected to exhibit a CAGR of 5.1% during 2024-2034. The retinopathy of prematurity market has been comprehensively analyzed in IMARC's new report ti...

May 2024 139 pages

Filters

Search

Categories

57
23,521
370
94
999
914
541
405
240
22
8,559
251
675
84
1,065
4
507
19
241
547
553
305
23
177
39
33,609
40
139
353
702
23
152
69
5,333
95
1,835
167
48
819
116
1,162
657
549
1,866
4,252
1,146
70
110,523
509
48,729
94

Publishers

251
21
1
4
204
62
262
243
2
922
79
698
53
68
583
106
6,695
6,889
30,350
501
2,483
5,841
1
3
1
1
484
7
1,083
7,751
450
142
448
1
2,189
1
136
9
1,696
8
29
79
6
2
75
11,736
2,426
698
6
10,807
171
1
321
1,034
1
33,621
484
66
5
5
214
2
1,360
5,811
151
56
481
149
148
214
3,604
3
4
536
197
15
23
3
107
22
19,652
31
31
1
16
89
9,602
54
143
74
807
1
1,261
2,133
48
220
29
5
11,194
2
45
173
10
108
5
482
11
33
21
160
348
36
110
436
2
89
186
8
313
5
3
386
4
118
58
53
61
8
20
120
111
2
9
1
1,866
1
13
10
5
492
1
1
15
1
38
2
3
28
7
3
1
207
7
1
306
6
368
3
280
51
43,810
140
1
2
4
114
2
16
9
43
26
1
212
3
9
4
22
1
2,327
3,738
1
2
3
220
400
78
689
970
388
206
160
8
47
32
328
38
4
1,155
7

Regions

247
231
217
215
215
200
198
197
196
156
154
140
140
140
136
136
131
19
18
17
17
15
11
10
7
6
5
5
4
4
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
256
39
158
6,398
1,652
1,545
1,417
1,384
1,367
1,363
346
330
310
300
298
288
287
283
276
274
274
274
273
272
271
268
267
267
266
265
265
264
261
261
260
259
255
254
254
253
252
249
242
232
226
226
221
203
196
190
190
181
161
151
67
36
33
26
14
2
134
131
5,387
317
287
281
7,450
3,586
412
198
114
182,781
208
191
195
474
472
296
290
267
249
155
175
32
238
173
163
155
236
193
17
143
32
238
36
4,814
4,304
8,010

Price

Date

Pages

Offers

257
112
1
384
7
5
17